Literature DB >> 22291210

Migration of monocytes after intracerebral injection at entorhinal cortex lesion site.

Miriam Kaminski1, Ingo Bechmann, Martin Pohland, Jürgen Kiwit, Robert Nitsch, Jana Glumm.   

Abstract

The lack of classical lymph vessels within brain tissue complicates immune surveillance of the CNS, and therefore, cellular emigration out of the CNS parenchyma requires alternate pathways. Whereas invasion of blood-derived mononuclear cells and their transformation into ramified, microglia-like cells in areas of axonal degeneration across an intact BBB have been demonstrated, it still remained unclear whether these cells reside permanently, undergo apoptosis, or leave the brain to present antigen in lymphoid organs. With the use of ECL of mice and injection of GFP-expressing monocytes, we followed the appearance of injected cells in spleen and LNs and the migratory pathways in whole-head histological sections. Monocytes migrated from the lesion site to deep CLNs, peaking in number at Day 7, but they were virtually absent in spleen and in superficial CLNs and inguinal LNs until Day 21 after lesion/injection. In whole-head sections, GFP monocytes were found attached to the olfactory nerves and located within the nasal mucosa at 48 hpi. Thus, monocytes are capable of migrating from lesioned brain areas to deep CLNs and use the cribriform plate as an exit route.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22291210     DOI: 10.1189/jlb.0511241

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  36 in total

1.  Migration of monocytes after intracerebral injection.

Authors:  Miriam Kaminski; Ingo Bechmann; Jürgen Kiwit; Jana Glumm
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

Review 2.  Microglial phenotype and adaptation.

Authors:  B J L Eggen; D Raj; U-K Hanisch; H W G M Boddeke
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

Review 3.  The movers and shapers in immune privilege of the CNS.

Authors:  Britta Engelhardt; Peter Vajkoczy; Roy O Weller
Journal:  Nat Immunol       Date:  2017-01-16       Impact factor: 25.606

Review 4.  Dendritic cells in central nervous system autoimmunity.

Authors:  Christopher Sie; Thomas Korn
Journal:  Semin Immunopathol       Date:  2016-11-25       Impact factor: 9.623

Review 5.  Brain dendritic cells: biology and pathology.

Authors:  Paul M D'Agostino; Andres Gottfried-Blackmore; Niroshana Anandasabapathy; Karen Bulloch
Journal:  Acta Neuropathol       Date:  2012-07-24       Impact factor: 17.088

Review 6.  Principles of immunology and its nuances in the central nervous system.

Authors:  Gavin P Dunn; Hideho Okada
Journal:  Neuro Oncol       Date:  2015-11       Impact factor: 12.300

Review 7.  Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?

Authors:  Antoine Louveau; Sandro Da Mesquita; Jonathan Kipnis
Journal:  Neuron       Date:  2016-09-07       Impact factor: 17.173

Review 8.  Revisiting the Mechanisms of CNS Immune Privilege.

Authors:  Antoine Louveau; Tajie H Harris; Jonathan Kipnis
Journal:  Trends Immunol       Date:  2015-10       Impact factor: 16.687

Review 9.  Understanding the functions and relationships of the glymphatic system and meningeal lymphatics.

Authors:  Antoine Louveau; Benjamin A Plog; Salli Antila; Kari Alitalo; Maiken Nedergaard; Jonathan Kipnis
Journal:  J Clin Invest       Date:  2017-09-01       Impact factor: 14.808

Review 10.  Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.

Authors:  Katharina Maisel; Maria Stella Sasso; Lambert Potin; Melody A Swartz
Journal:  Adv Drug Deliv Rev       Date:  2017-07-08       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.